NRN1L
gene geneOn this page
Also known as UNQ2446MRCC2446
Summary
NRN1L (neuritin 1 like, HGNC:29811) is a protein-coding gene on chromosome 16q22.1, encoding Neuritin-like protein (Q496H8).
The protein encoded by this gene is extracellular and enhances both neurite growth and neuronal survival. The encoded protein is found both as a GPI anchored membrane-bound form and as a secreted form. This activity-related ligand functions as a homodimer or heterodimer.
Source: NCBI Gene 123904 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 35 total
- MANE Select transcript:
NM_198443
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29811 |
| Approved symbol | NRN1L |
| Name | neuritin 1 like |
| Location | 16q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | UNQ2446, MRCC2446 |
| Ensembl gene | ENSG00000188038 |
| Ensembl biotype | protein_coding |
| Entrez | 123904 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000339176, ENST00000576147, ENST00000576758
RefSeq mRNA: 2 — MANE Select: NM_198443
NM_001348682, NM_198443
CCDS: CCDS10850
Canonical transcript exons
ENST00000339176 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001382483 | 67885722 | 67885854 |
| ENSE00001384007 | 67885974 | 67886368 |
| ENSE00002659087 | 67884885 | 67884982 |
Expression profiles
Bgee: expression breadth ubiquitous, 131 present calls, max score 79.92.
FANTOM5 (CAGE): breadth broad, TPM avg 1.4366 / max 257.7276, expressed in 258 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 154691 | 1.4366 | 258 |
Top tissues by expression
133 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.92 | silver quality |
| putamen | UBERON:0001874 | 78.14 | gold quality |
| adrenal tissue | UBERON:0018303 | 77.77 | gold quality |
| caudate nucleus | UBERON:0001873 | 75.16 | gold quality |
| nucleus accumbens | UBERON:0001882 | 74.93 | gold quality |
| adenohypophysis | UBERON:0002196 | 74.49 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 74.29 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 74.23 | gold quality |
| cerebellar cortex | UBERON:0002129 | 74.08 | gold quality |
| cerebellum | UBERON:0002037 | 73.98 | gold quality |
| pituitary gland | UBERON:0000007 | 73.48 | gold quality |
| hypothalamus | UBERON:0001898 | 72.83 | gold quality |
| apex of heart | UBERON:0002098 | 70.50 | gold quality |
| granulocyte | CL:0000094 | 70.36 | gold quality |
| brain | UBERON:0000955 | 69.65 | gold quality |
| left ovary | UBERON:0002119 | 68.96 | gold quality |
| amygdala | UBERON:0001876 | 68.68 | gold quality |
| temporal lobe | UBERON:0001871 | 68.66 | gold quality |
| substantia nigra | UBERON:0002038 | 68.24 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 67.86 | gold quality |
| right ovary | UBERON:0002118 | 67.59 | gold quality |
| Ammon’s horn | UBERON:0001954 | 67.55 | gold quality |
| prefrontal cortex | UBERON:0000451 | 66.83 | gold quality |
| tibial nerve | UBERON:0001323 | 66.78 | gold quality |
| right uterine tube | UBERON:0001302 | 66.59 | gold quality |
| ovary | UBERON:0000992 | 66.55 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 66.26 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 65.98 | gold quality |
| popliteal artery | UBERON:0002250 | 65.69 | gold quality |
| tibial artery | UBERON:0007610 | 65.68 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7316 | yes | 37.47 |
| E-MTAB-6142 | no | 10.08 |
| E-ANND-3 | no | 0.72 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
3 targeting NRN1L, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-3158-5P | 99.65 | 67.51 | 1763 |
| HSA-MIR-6782-3P | 97.60 | 67.75 | 931 |
Literature-anchored findings (GeneRIF, showing 1)
- CPG15 and CPG15-2 perform similar cellular functions but may play distinct roles in vivo through their cell-type- and tissue-specific transcriptional regulation. (PMID:18265009)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | nrn1lb | ENSDARG00000061149 |
| danio_rerio | nrn1la | ENSDARG00000069368 |
| mus_musculus | Nrn1l | ENSMUSG00000044287 |
Paralogs (1): NRN1 (ENSG00000124785)
Protein
Protein identifiers
Neuritin-like protein — Q496H8 (reviewed: Q496H8)
All UniProt accessions (3): Q496H8, I3L2K6, J3QS81
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cell membrane.
Similarity. Belongs to the neuritin family.
RefSeq proteins (2): NP_001335611, NP_940845* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026144 | Neuritin_fam | Family |
Pfam: PF15056
UniProt features (4 total): signal peptide 1, chain 1, propeptide 1, lipid moiety-binding region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q496H8-F1 | 73.23 | 0.32 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 139
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-163125 | Post-translational modification: synthesis of GPI-anchored proteins |
MSigDB gene sets: 56 (showing top):
chr16q22, GOBP_NEURON_PROJECTION_EXTENSION, GOBP_GROWTH, GOBP_NEUROGENESIS, FOXO1_01, NKX61_01, TGANTCA_AP1_C, NRF2_Q4, GOBP_DEVELOPMENTAL_CELL_GROWTH, GOCC_NEURON_PROJECTION, GOBP_CELL_PROJECTION_ORGANIZATION, CCCNNGGGAR_OLF1_01, GOBP_DEVELOPMENTAL_GROWTH_INVOLVED_IN_MORPHOGENESIS, NFE2_01, FOXO4_02
GO Biological Process (2): neuron projection extension (GO:1990138), nervous system development (GO:0007399)
GO Molecular Function (2): identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (6): extracellular region (GO:0005576), obsolete extracellular space (GO:0005615), plasma membrane (GO:0005886), axon (GO:0030424), side of membrane (GO:0098552), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Post-translational protein modification | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| membrane | 2 |
| developmental cell growth | 1 |
| neuron projection morphogenesis | 1 |
| developmental growth involved in morphogenesis | 1 |
| system development | 1 |
| protein binding | 1 |
| binding | 1 |
| cell periphery | 1 |
| neuron projection | 1 |
| leaflet of membrane bilayer | 1 |
Protein interactions and networks
STRING
215 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NRN1L | KIAA1143 | Q96AT1 | 540 |
| NRN1L | RPRML | Q8N4K4 | 526 |
| NRN1L | TSTD1 | Q8NFU3 | 428 |
| NRN1L | PLA2G4F | Q68DD2 | 398 |
| NRN1L | ZC3H3 | Q8IXZ2 | 375 |
| NRN1L | DIPK1A | Q5T7M9 | 374 |
| NRN1L | SHROOM4 | Q9ULL8 | 371 |
| NRN1L | PLA2G4D | Q86XP0 | 366 |
| NRN1L | CFAP65 | Q6ZU64 | 358 |
| NRN1L | CERCAM | Q5T4B2 | 351 |
| NRN1L | SLC35A5 | Q9BS91 | 350 |
| NRN1L | SLC25A2 | Q9BXI2 | 336 |
| NRN1L | PLAC1 | Q9HBJ0 | 330 |
| NRN1L | MICALL2 | Q8IY33 | 319 |
| NRN1L | NUDT12 | Q9BQG2 | 311 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NRN1L | UBQLN2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NRN1L | SLC39A10 | psi-mi:“MI:0915”(physical association) | 0.400 |
| UBQLN2 | NRN1L | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (3): NRN1L (Reconstituted Complex), NRN1L (Two-hybrid), SLC39A10 (Affinity Capture-MS)
ESM2 similar proteins: A0MLS4, A2BDG0, A2BDG5, A2BDG9, A2RRL7, A3KN25, A6NGB7, G1TZA0, O14669, O77751, O77801, O95868, P01286, P02820, P02822, P0DUJ6, P24807, P25063, P27177, P41547, P51460, P63292, P98162, Q01524, Q08DF2, Q1ECT8, Q1JPW9, Q496H8, Q58CU5, Q5CZK3, Q5G860, Q5G863, Q5HZE8, Q60549, Q64697, Q6BEG6, Q7TPG6, Q8C4W3, Q8R182, Q923S2
Diamond homologs: O08957, Q2KIC6, Q496H8, Q5U523, Q6DGP8, Q8C4W3, Q8CFV4, Q90ZM9, Q9NPD7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
35 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 27 |
| Likely benign | 3 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
384 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:67884979:CTCGG:C | donor_loss | 1.0000 |
| 16:67884980:TCGGT:T | donor_loss | 1.0000 |
| 16:67884981:CGGTG:C | donor_loss | 1.0000 |
| 16:67884982:GGT:G | donor_loss | 1.0000 |
| 16:67884983:G:GG | donor_gain | 1.0000 |
| 16:67884983:G:T | donor_loss | 1.0000 |
| 16:67884984:T:A | donor_loss | 1.0000 |
| 16:67885721:GTCCT:G | acceptor_gain | 1.0000 |
| 16:67885737:T:TA | acceptor_gain | 1.0000 |
| 16:67884985:GAGT:G | donor_loss | 0.9900 |
| 16:67885720:A:AG | acceptor_gain | 0.9900 |
| 16:67885721:G:GG | acceptor_gain | 0.9900 |
| 16:67885721:GTCC:G | acceptor_gain | 0.9900 |
| 16:67885741:A:AG | acceptor_gain | 0.9900 |
| 16:67885742:G:GG | acceptor_gain | 0.9900 |
| 16:67885742:GCA:G | acceptor_gain | 0.9900 |
| 16:67885850:TGCAG:T | donor_loss | 0.9900 |
| 16:67885853:AGGTA:A | donor_loss | 0.9900 |
| 16:67885855:G:GA | donor_loss | 0.9900 |
| 16:67884978:CCTCG:C | donor_gain | 0.9800 |
| 16:67884979:CTCG:C | donor_gain | 0.9800 |
| 16:67884980:TCG:T | donor_gain | 0.9800 |
| 16:67884981:CG:C | donor_gain | 0.9800 |
| 16:67884982:GG:G | donor_gain | 0.9800 |
| 16:67885738:G:A | acceptor_gain | 0.9800 |
| 16:67885742:GC:G | acceptor_gain | 0.9800 |
| 16:67885721:GTC:G | acceptor_gain | 0.9700 |
| 16:67885721:GT:G | acceptor_gain | 0.9500 |
| 16:67885834:C:T | donor_gain | 0.9500 |
| 16:67885852:C:T | donor_gain | 0.9500 |
AlphaMissense
1033 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:67886046:G:C | W95C | 0.995 |
| 16:67886046:G:T | W95C | 0.995 |
| 16:67885980:G:C | W73C | 0.992 |
| 16:67885980:G:T | W73C | 0.992 |
| 16:67885987:T:C | F76L | 0.984 |
| 16:67885989:C:A | F76L | 0.984 |
| 16:67885989:C:G | F76L | 0.984 |
| 16:67885988:T:G | F76C | 0.983 |
| 16:67885788:T:G | F49C | 0.982 |
| 16:67885787:T:C | F49L | 0.973 |
| 16:67885789:C:A | F49L | 0.973 |
| 16:67885789:C:G | F49L | 0.973 |
| 16:67885788:T:C | F49S | 0.967 |
| 16:67885978:T:A | W73R | 0.961 |
| 16:67885978:T:C | W73R | 0.961 |
| 16:67885988:T:C | F76S | 0.959 |
| 16:67886044:T:A | W95R | 0.956 |
| 16:67886044:T:C | W95R | 0.956 |
| 16:67886093:T:C | L111S | 0.950 |
| 16:67885796:T:C | C52R | 0.948 |
| 16:67886104:T:A | C115S | 0.945 |
| 16:67886105:G:C | C115S | 0.945 |
| 16:67885850:T:A | C70S | 0.943 |
| 16:67885851:G:C | C70S | 0.943 |
| 16:67886000:C:A | A80D | 0.943 |
| 16:67885796:T:A | C52S | 0.942 |
| 16:67885797:G:C | C52S | 0.942 |
| 16:67885800:T:A | L53H | 0.940 |
| 16:67885812:G:T | G57V | 0.939 |
| 16:67886020:T:A | C87S | 0.933 |
dbSNP variants (sampled 300 via entrez): RS1001308848 (16:67883857 C>T), RS1002574737 (16:67887555 C>G), RS1002623305 (16:67887066 G>A), RS1002830792 (16:67888816 A>G), RS1003218996 (16:67887052 G>A), RS1004112170 (16:67889336 T>A,C,G), RS1004146088 (16:67886413 G>A,T), RS1004496431 (16:67886774 C>T), RS1004657234 (16:67884738 G>C), RS1005637898 (16:67887860 G>A), RS1005764997 (16:67885648 C>G,T), RS1006231663 (16:67885506 C>G), RS1006512898 (16:67884673 C>G), RS1006612826 (16:67885201 G>A), RS1007058327 (16:67888710 G>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002539_84 | Schizophrenia | 2.000000e-08 |
| GCST006803_42 | Schizophrenia | 4.000000e-08 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cisplatin | affects expression, affects cotreatment, decreases expression | 2 |
| terbufos | increases methylation | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| pentanal | decreases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| Decitabine | affects expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Fonofos | increases methylation | 1 |
| Gallic Acid | decreases expression | 1 |
| Parathion | increases methylation | 1 |
| Silver | increases expression | 1 |
| Smoke | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.